| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 34.438 | 67.148 | 106.508 | 88.095 | 66.968 | 71.951 | 86.821 | 82.727 | 96.857 | 107.604 |
| Total Income - EUR | 55.691 | 82.330 | 121.232 | 101.570 | 80.184 | 84.914 | 99.498 | 95.443 | 98.990 | 107.631 |
| Total Expenses - EUR | 52.338 | 69.960 | 90.422 | 89.569 | 80.272 | 83.722 | 90.479 | 96.186 | 95.993 | 104.737 |
| Gross Profit/Loss - EUR | 3.354 | 12.370 | 30.810 | 12.001 | -89 | 1.192 | 9.019 | -743 | 2.997 | 2.894 |
| Net Profit/Loss - EUR | 2.320 | 11.698 | 29.745 | 11.120 | -758 | 716 | 8.211 | -1.554 | 2.048 | -271 |
| Employees | 3 | 3 | 3 | 11 | 3 | 5 | 3 | 3 | 4 | 4 |
Check the financial reports for the company - Oncogin Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 128.601 | 108.432 | 88.304 | 69.845 | 51.981 | 34.796 | 18.419 | 2.628 | 0 | 0 |
| Current Assets | 11.243 | 21.047 | 54.164 | 39.142 | 41.034 | 44.178 | 54.325 | 14.253 | 18.858 | 18.400 |
| Inventories | 510 | 242 | 711 | 373 | 238 | 376 | 378 | 648 | 552 | 555 |
| Receivables | 23 | 22 | 212 | 470 | 372 | 384 | 782 | 800 | 771 | 1.200 |
| Cash | 10.710 | 20.782 | 53.240 | 38.298 | 40.423 | 43.418 | 53.165 | 12.804 | 17.535 | 16.646 |
| Shareholders Funds | 2.423 | 11.800 | 41.346 | 51.707 | 49.948 | 49.717 | 56.825 | 12.758 | 14.767 | -179 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 34.063 | 117.759 | 30.307 | 1.350 | 1.221 | 1.169 | 1.239 | 2.123 | 4.227 | 18.695 |
| Income in Advance | 103.358 | 87.123 | 70.924 | 56.147 | 41.845 | 28.088 | 14.789 | 2.119 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Oncogin Med S.r.l.